BU-NOT-SET

CONTACT US
The power of analytics and AI in the era of continuous RNA manufacturing
  • Biologics
people in a lab
Insight
Reimagining the RNA manufacturing space: An interview with ReciBioPharm’s leaders
  • Biologics
person in lab
Insight
Unlocking the potential of mRNA: Inside ReciBioPharm's Watertown site
  • Biologics
mRNA
Insight
Industry 5.0 in action: AI-driven continuous manufacturing for RNA therapeutics
  • Biologics
vaccine in bottles
Insight
Choosing the optimal container format for sterile drug products
  • Drug product
  • Manufacturing
Containers for sterile drug products
Insight
FDA inspection success at Recipharm’s site in Bengaluru, India
  • Manufacturing
Two people looking at a printed document
Insight
Lyophilisation Services
  • Drug product
  • Manufacturing
bottles
Fact sheet
Using blow-fill-seal technology for biologic and vaccine delivery
  • Drug product
  • Manufacturing
blow-fill-seal
Insight
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
vials
Webinar
White paper
  • Analytical chemistry
  • Drug product
Developing a robust dissolution method for low-dose formulations
Report
  • Sustainability
Sustainability report 2022
Insight
  • Drug product
  • Industry trends
Navigating the changing oral solid dose landscape
Insight
  • Drug product
  • Manufacturing
The opportunities and obstacles of filling and packaging pre-filled syringes
Insight
  • Drug product
  • Industry trends
Tips for facilitating a successful tech transfer between sponsor and CDMO
Insight
  • Drug product
  • Industry trends
Alternative drug delivery formulation & device expertise
Insight
  • Industry trends
The 3 key trends shaping the CDMO industry in 2023 and beyond
Insight
  • Drug product
  • Industry trends
Three challenges pharma companies can overcome when choosing the right OSD partner
Insight
  • Sustainability
Sustainable pharmaceutical supply chains with the Science Based Targets initiative